ATE550336T1 - Ä1,2,3ü-triazolyl-substituierte chinoline und coumarine als leukotrien-biosynthese-hemmer - Google Patents
Ä1,2,3ü-triazolyl-substituierte chinoline und coumarine als leukotrien-biosynthese-hemmerInfo
- Publication number
- ATE550336T1 ATE550336T1 AT08714553T AT08714553T ATE550336T1 AT E550336 T1 ATE550336 T1 AT E550336T1 AT 08714553 T AT08714553 T AT 08714553T AT 08714553 T AT08714553 T AT 08714553T AT E550336 T1 ATE550336 T1 AT E550336T1
- Authority
- AT
- Austria
- Prior art keywords
- leucotrien
- coumarines
- triazolyl
- biosynthesis inhibitors
- substituted quinolines
- Prior art date
Links
- 229940111121 antirheumatic drug quinolines Drugs 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003248 quinolines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89947107P | 2007-02-05 | 2007-02-05 | |
| US90035307P | 2007-02-08 | 2007-02-08 | |
| PCT/CA2008/000230 WO2008095292A1 (en) | 2007-02-05 | 2008-02-05 | [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE550336T1 true ATE550336T1 (de) | 2012-04-15 |
Family
ID=39676707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08714553T ATE550336T1 (de) | 2007-02-05 | 2008-02-05 | Ä1,2,3ü-triazolyl-substituierte chinoline und coumarine als leukotrien-biosynthese-hemmer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7960409B2 (de) |
| EP (1) | EP2118093B1 (de) |
| JP (1) | JP5514554B2 (de) |
| CN (1) | CN101657443B (de) |
| AR (1) | AR065093A1 (de) |
| AT (1) | ATE550336T1 (de) |
| AU (1) | AU2008213767B2 (de) |
| CA (1) | CA2676498A1 (de) |
| CL (1) | CL2008000307A1 (de) |
| PE (1) | PE20090041A1 (de) |
| TW (1) | TW200838511A (de) |
| WO (2) | WO2008095292A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100120578A1 (en) * | 2008-11-07 | 2010-05-13 | Hichem Bouguerra | Drive and steering control system for an endless track vehicle |
| CN102050809B (zh) * | 2009-11-03 | 2014-12-17 | 中国医学科学院药物研究所 | 拮抗cklf1/ccr4相互作用的3-哌嗪基香豆素衍生物 |
| PT2770989T (pt) | 2011-10-26 | 2018-12-04 | Allergan Inc | Derivados de amida de aminoácidos substituídos por n-ureia como moduladores de recetor tipo-1 do recetor de péptidos formil (fprl-1) |
| MX344308B (es) * | 2011-11-03 | 2016-12-13 | Merck Sharp & Dohme | Derivados de quinolina carboxamida y quinolina carbonitrilo como moduladores alostericos negativos de mglur2, composiciones y su uso. |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| US9309222B2 (en) | 2012-10-16 | 2016-04-12 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| JP6466335B2 (ja) | 2012-10-16 | 2019-02-06 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲ−γ−Ｔのメチレン連結キノリニルモジュレーター |
| CN104884448A (zh) | 2012-10-16 | 2015-09-02 | 詹森药业有限公司 | Rorγt的杂芳基连接的喹啉基调节剂 |
| EP2970177A1 (de) | 2013-03-15 | 2016-01-20 | Pfizer Inc. | Indolverbindungen zur ampk-aktivierung |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| KR20160068948A (ko) | 2013-10-15 | 2016-06-15 | 얀센 파마슈티카 엔.브이. | RORyt의 이차 알코올 퀴놀리닐 조절제 |
| KR20160068956A (ko) | 2013-10-15 | 2016-06-15 | 얀센 파마슈티카 엔.브이. | RORyT의 퀴놀리닐 조절제 |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| CN105873439A (zh) | 2013-10-15 | 2016-08-17 | 詹森药业有限公司 | RORγt的烷基连接的喹啉基调节剂 |
| CA2999200C (en) * | 2015-09-24 | 2021-03-30 | Guizhou Bailing Group Pharmaceutical Co., Ltd. | 4-substituted coumarin derivatives and preparation methods and uses thereof |
| CR20190147A (es) | 2016-09-27 | 2019-05-17 | Merck Sharp & Dohme | DERIVADOS DE CROMANO, ISOCROMANO Y DIHIDROISOBENZOFURANOS COMO MODULADORES ALOSTÉRICOS NEGATIVOS DE mGluR2, COMPOSICIONES Y SU USO |
| US11344543B2 (en) * | 2017-07-14 | 2022-05-31 | Innate Tumor Immunity, Inc. | NLRP3 modulators |
| CN108299369B (zh) * | 2018-01-15 | 2021-07-30 | 安徽师范大学 | 香豆素-4-磺酸酯衍生物及其制备方法 |
| AU2019375983A1 (en) | 2018-11-09 | 2021-06-10 | Vivace Therapeutics, Inc. | Bicyclic compounds |
| IL287222B2 (en) | 2019-04-16 | 2025-04-01 | Vivace Therapeutics Inc | Bicyclic compounds |
| CN110038012B (zh) * | 2019-05-30 | 2021-06-11 | 济南大学 | 具有1,2,3-三氮唑结构片段的生物碱化合物在制备促血管生成药物中的应用 |
| US20240368106A1 (en) * | 2021-08-30 | 2024-11-07 | Pretzel Therapeutics, Inc. | Hydroxy and alkoxy coumarins as modulators of polrmt |
| WO2023034346A1 (en) * | 2021-08-30 | 2023-03-09 | Pretzel Therapeutics, Inc. | Chromen-2-one modulators of polrmt |
| CN114307937B (zh) * | 2022-02-24 | 2024-05-24 | 辽宁博仕科技股份有限公司 | 基于射流反应器的过一硫酸氢钾复合盐生产装置及方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5424320A (en) * | 1993-06-23 | 1995-06-13 | Merck Frosst Canada, Inc. | Heteroaryl coumarins as inhibitors of leukotriene biosynthesis |
| US5410054A (en) * | 1993-07-20 | 1995-04-25 | Merck Frosst Canada, Inc. | Heteroaryl quinolines as inhibitors of leukotriene biosynthesis |
| US5552437A (en) * | 1994-10-27 | 1996-09-03 | Merck Frosst Canada, Inc. | Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| CN1802372B (zh) * | 2003-06-11 | 2010-05-12 | 麦克弗罗斯特加拿大有限公司 | 7＇-(1,3-噻唑-2-基)-硫代香豆素及其作为白三烯生物合成抑制剂的应用 |
| AR055041A1 (es) * | 2005-03-23 | 2007-08-01 | Merck Frosst Canada Ltd | Tiadiazoles y oxadiazoles como inhibidores de la sintesis de leucotrienos. composiciones farmaceuticas. |
| CA2618586A1 (en) | 2005-08-11 | 2007-02-15 | Merck Frosst Canada Ltd. | Novel substituted 1,2,3-triazolylmethyl-benzothiophene or -indole and their use as leukotriene biosynthesis inhibitors |
-
2008
- 2008-01-30 AR ARP080100376A patent/AR065093A1/es unknown
- 2008-01-31 CL CL200800307A patent/CL2008000307A1/es unknown
- 2008-02-01 US US12/012,246 patent/US7960409B2/en not_active Expired - Fee Related
- 2008-02-01 TW TW097104101A patent/TW200838511A/zh unknown
- 2008-02-04 PE PE2008000245A patent/PE20090041A1/es not_active Application Discontinuation
- 2008-02-05 CN CN2008800112245A patent/CN101657443B/zh not_active Expired - Fee Related
- 2008-02-05 CA CA002676498A patent/CA2676498A1/en not_active Abandoned
- 2008-02-05 AU AU2008213767A patent/AU2008213767B2/en not_active Ceased
- 2008-02-05 JP JP2009547507A patent/JP5514554B2/ja not_active Expired - Fee Related
- 2008-02-05 AT AT08714553T patent/ATE550336T1/de active
- 2008-02-05 WO PCT/CA2008/000230 patent/WO2008095292A1/en not_active Ceased
- 2008-02-05 EP EP08714553A patent/EP2118093B1/de not_active Not-in-force
- 2008-02-05 WO PCT/CA2008/000231 patent/WO2008095293A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2118093A4 (de) | 2010-03-17 |
| AU2008213767A1 (en) | 2008-08-14 |
| CN101657443A (zh) | 2010-02-24 |
| PE20090041A1 (es) | 2009-02-07 |
| CL2008000307A1 (es) | 2008-05-30 |
| AR065093A1 (es) | 2009-05-13 |
| EP2118093A1 (de) | 2009-11-18 |
| WO2008095292A1 (en) | 2008-08-14 |
| US7960409B2 (en) | 2011-06-14 |
| CA2676498A1 (en) | 2008-08-14 |
| TW200838511A (en) | 2008-10-01 |
| EP2118093B1 (de) | 2012-03-21 |
| AU2008213767B2 (en) | 2013-06-06 |
| CN101657443B (zh) | 2013-10-23 |
| JP2010517947A (ja) | 2010-05-27 |
| US20080188521A1 (en) | 2008-08-07 |
| JP5514554B2 (ja) | 2014-06-04 |
| WO2008095293A1 (en) | 2008-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006008945D1 (de) | Isochinolinderivate als inhibitoren von rho-kinase | |
| ATE529421T1 (de) | Chinolinderivate als phosphodiesterase-hemmer | |
| ATE502027T1 (de) | Substituierte isochinoline und ihre verwendung als rho-kinase-inhibitoren | |
| DE602005016890D1 (de) | Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren | |
| DE602007014374D1 (de) | Ä4,5'ü-bipyrimidinyl-6,4'-diaminderivate als proteinkinase-hemmer | |
| ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
| ATE525374T1 (de) | Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren | |
| DK1720531T3 (da) | Nye sammensætninger indeholdende quinolinforbindelser | |
| ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
| ATE441639T1 (de) | 2,4-diamino-pyrimidine als aurora inhibitoren | |
| ATE524467T1 (de) | Neuartige aza-heterozyklen als kinase-inhibitoren | |
| ATE544758T1 (de) | Carboxamidverbindungen und ihre verwendung als calpain-hemmer | |
| ATE496029T1 (de) | Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren | |
| ATE512972T1 (de) | Pyrrolopyrazole als wirksame kinaseinhibitoren | |
| ATE541850T1 (de) | Pyrroloä2,3-cüpyridinderivate als p38-kinase- hemmende mittel | |
| ATE546433T1 (de) | Quinolinderivate und ihre verwendung als fungizide | |
| ATE493411T1 (de) | Pyrroloä2, 3-büpyridin-4-yl- benzolsulfonamidverbindungen als ikk2-hemmer | |
| ATE452635T1 (de) | Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer | |
| ATE543816T1 (de) | Azacycloalkanderivate als inhibitoren von stearoyl-coenzym-a-delta-9-desaturase | |
| DE602006015607D1 (de) | Thiazol-4-carboxamid-derivate als mglur5-antagonisten | |
| ATE404564T1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
| ATE423121T1 (de) | Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren | |
| ATE492545T1 (de) | Verbindungen und zusammensetzungen als proteinkinase-hemmer | |
| ATE472543T1 (de) | Heteroaromatische chinolinverbindungen und deren verwendung als pde10-inhibitoren | |
| EP2118093A4 (de) | [1,2,3]-triazolyl-substituierte chinoline und coumarine als leukotrien-biosynthese-hemmer |